Back to Search
MATTHEW BALLINGER, D.M.D.
D.M.D.
General Practice Dentistry
NPI: 1740302389Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
12605(MD)
Research & Publications (20)
Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL.
PMID 19217622·Atherosclerosis·2009
8-other
Scaled tests and modeling of effluent stack sampling location mixing.
PMID 19131738·Health Phys·2009
8-other
Crosstalk between prostaglandin E2 and leukotriene B4 regulates phagocytosis in alveolar macrophages via combinatorial effects on cyclic AMP.
PMID 19109185·J Immunol·2009
7-preclinical
Growth factor-mediated hyper-elongation of glycosaminoglycan chains on biglycan requires transcription and translation.
PMID 19580379·Arch Physiol Biochem·2009
8-other
Fragment-based discovery of nonpeptidic BACE-1 inhibitors using tethering.
PMID 19284778·Biochemistry·2009
8-other
The Aurora kinase inhibitor SNS-314 shows broad therapeutic potential with chemotherapeutics and synergy with microtubule-targeted agents in a colon carcinoma model.
PMID 19372566·Mol Cancer Ther·2009
7-preclinical
Phosphorylated troglitazone activates PPARgamma and inhibits vascular smooth muscle cell proliferation and proteoglycan synthesis.
PMID 18356692·J Cardiovasc Pharmacol·2008
7-preclinical
Cyclic AMP: master regulator of innate immune cell function.
PMID 18323530·Am J Respir Cell Mol Biol·2008
6-review
Cardiac function and myocardial perfusion immediately following maximal treadmill exercise inside the MRI room.
PMID 18272005·J Cardiovasc Magn Reson·2008
8-other
Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle.
PMID 18223258·J Biol Chem·2008
8-other
Biosynthesis of natural and hyperelongated chondroitin sulfate glycosaminoglycans: new insights into an elusive process.
PMID 19238187·Open Biochem J·2008
8-other
p38 MAP kinase mediated proteoglycan synthesis as a target for the prevention of atherosclerosis.
PMID 19075640·Cardiovasc Hematol Disord Drug Targets·2008
6-review
Pyrido-pyrimidine derivative CYC10424 inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans and reduces lipoprotein binding.
PMID 19033819·J Cardiovasc Pharmacol·2008
8-other
Comparison of conditioning regimens for alveolar macrophage reconstitution and innate immune function post bone marrow transplant.
PMID 18465404·Exp Lung Res·2008
4-observational
Paradoxical role of alveolar macrophage-derived granulocyte-macrophage colony-stimulating factor in pulmonary host defense post-bone marrow transplantation.
PMID 18456799·Am J Physiol Lung Cell Mol Physiol·2008
7-preclinical
Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis.
PMID 17583182·Vasc Health Risk Manag·2007
6-review
Anti-proliferative activity of oral anti-hyperglycemic agents on human vascular smooth muscle cells: thiazolidinediones (glitazones) have enhanced activity under high glucose conditions.
PMID 17963526·Cardiovasc Diabetol·2007
8-other
Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase.
PMID 17585108·Am J Respir Cell Mol Biol·2007
7-preclinical
Glycosaminoglycan synthesis and structure as targets for the prevention of calcific aortic valve disease.
PMID 17560967·Cardiovasc Res·2007
6-review
Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities.
PMID 17237412·J Immunol·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 ELM ST, LOWER SUITE
PITTSFIELD, MA 01201 - Phone
- (443) 610-7591
Quick Facts
- NPI
- 1740302389
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile